share_log

HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Short Interest Down 84.1% in November

HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Short Interest Down 84.1% in November

港灣生命科學公司(OTCMK:HAVLF)十一月份短期利息下降 84.1%
kopsource ·  2022/12/13 10:41

HAVN Life Sciences Inc. (OTCMKTS:HAVLF – Get Rating) saw a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 2,400 shares, a decline of 84.1% from the November 15th total of 15,100 shares. Based on an average daily trading volume, of 24,500 shares, the days-to-cover ratio is currently 0.1 days.

11月份,HAvn Life Science Inc.(場外市場代碼:HAVLF-GET Rating)的空頭股數銷量大幅下降。截至11月30日,空頭股數共有2400股,比11月15日的15100股下降了84.1%。以日均成交量24,500股計算,目前天數與回補比率為0.1天。

HAVN Life Sciences Price Performance

擁有生命科學的性價比

OTCMKTS HAVLF traded down $0.00 on Monday, reaching $0.05. The stock had a trading volume of 327 shares, compared to its average volume of 5,594. HAVN Life Sciences has a 12-month low of $0.05 and a 12-month high of $4.96. The business's 50-day moving average price is $0.07 and its 200 day moving average price is $0.59.

週一,OTCMKTS HAVLF股價下跌0.00美元,至0.05美元。該股成交量為327股,而其平均成交量為5594股。HAvn Life Sciences的股價為0.05美元,為12個月低點,12個月高位為4.96美元。該業務的50日移動均線價格為0.07美元,200日移動均線價格為0.59美元。

Get
到達
HAVN Life Sciences
擁有生命科學學位
alerts:
警報:

About HAVN Life Sciences

關於HAVN生命科學

(Get Rating)

(獲取評級)

HAVN Life Sciences Inc, a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp.
HAVN生命科學公司是一家生物技術公司,從事從植物和真菌中提取的精神藥理產品的研究和開發。該公司還專注於開發從植物和真菌(包括裸子菌屬)中標準化和質量控制地提取精神活性化合物的方法。

Recommended Stories

推薦故事

  • Get a free copy of the StockNews.com research report on HAVN Life Sciences (HAVLF)
  • Three Small-Cap Biotech Stocks to Consider Now
  • Two Blue Chip Health Companies The Institutions Are Buying
  • What To Expect From The Q4 Earnings Reporting Season
  • Here's What to Expect for the S&P 500 in 2023
  • Can Bilibili be the Chinese Version of YouTube?
  • 免費獲取StockNews.com關於HAVN生命科學的研究報告(HAVLF)
  • 現在要考慮的三隻小盤生物科技股
  • 這兩家機構正在收購的兩家藍籌健康公司
  • 第四季度財報季的預期是什麼
  • 以下是對2023年標準普爾500指數的預期
  • 嗶哩嗶哩能成為中國版的YouTube嗎?

Receive News & Ratings for HAVN Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HAVN Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

接受《HAVN生命科學日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對HAVN生命科學和相關公司的最新新聞和分析師評級的每日簡要摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論